The global endoscopy procedure market is expected to reach US$ 53,196.65 million in 2030 from US$ 30,877.37 million in 2022. The market is estimated to grow with a CAGR of 7.0% from 2022 to 2030.
The key factors that are driving the growth of market are growing preference for minimally invasive surgeries and the increasing prevalence of chronic diseases. However, the risks of infections associated with endoscopic procedures hamper the market growth.
In April 2021, Ambu Inc. received Health Canada authorization for the aScope 4 Cysto, the company's unique flexible cystoscope platform for urology. Ambu’s aScope 4 Cysto is a cost-effective, high-quality flexible endoscope featuring excellent maneuverability and optics. Unlike traditional reusable endoscopes, single-use eliminates the significant capital, repair, and cleaning costs required to ensure a patient-ready instrument for every procedure. Each aScope 4 cystoscope is sterile from the package and ready when needed, enabling facilities to improve workflow efficiencies and reallocate staff from complex, time-consuming endoscope cleaning to more productive activities.
In December 2021, Medtronic Canada ULC, a subsidiary of Medtronic plc, received a Health Canada license for the Hugo robotic-assisted surgery (RAS) system for use in urologic and gynecologic laparoscopic surgical procedures, which make up about half of all robotic procedures performed in Canada. A modular, multi-quadrant platform indicated for urologic surgical procedures and gynecologic laparoscopic surgical procedures, the Hugo RAS system combines wristed instruments, 3D visualization, and a cloud-based surgical video capture option in Touch Surgery Enterprise with dedicated support teams specializing in robotics program optimization, service, and training.
In November 2022, PENTAX Medical launched the new Performance Endoscopic Ultrasound (EUS) system, a combination of the new ARIETTA 65 PX ultrasound scanner and their best-in-class J10 Series Ultrasound Gastroscopes in Canada. The ARIETTA 65 PX Performance ultrasound scanner is built for the endoscopic ultrasound practitioner focused on productivity. The system delivers brilliant imaging and value through its combination with the J10 Series Ultrasound Gastroscopes to efficiently manage high case volumes with ease.
On April 12, 2021, Cosmo Pharmaceuticals NV announced the FDA approval of the GI Genius intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy. The device is the first of its kind to obtain the FDA approval through the De Novo application. The device operates in real time to assist the endoscopist in the detection of lesions, is very simple to use and is compatible with all endoscopes. Cosmo is the sole manufacturer.On December 2019, Boston Scientific Corporation launched “EXALT Model D” a Single-Use Duodenoscope for endoscopic retrograde cholangiopancreatography procedures. This is the world’s first single-use duodenoscope. The third generation EXALT Model D Single-Use Duodenoscope has incorporated a number of design updates based on physician feedback that are intended to improve the overall user experience.
Thus, all these recent developments are expected to provide growth opportunities for the market over the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the endoscopy procedure market are the FDA (Food and Drug Administration), EUA (Emergency Use Authorization), EMA (European Medicines Agency), and EPA (Environmental Protection Agency)
Reasons to Buy
The key factors that are driving the growth of market are growing preference for minimally invasive surgeries and the increasing prevalence of chronic diseases. However, the risks of infections associated with endoscopic procedures hamper the market growth.
Technological Advancement Leading to Enhanced Applications Opportunity for Growth of Endoscopy Procedure Market
The field of endoscopy in North America has witnessed various technological advancements and product launches. Such advancements are not only expected to help in the accurate diagnosis of a condition but also will help improve the safety of endoscopic procedures.Some recent technological advancements and product launches are listed below:
In April 2021, Olympus announced the addition to its U.S. bronchoscopy portfolio of the 510(k)-cleared H-SteriScope Single-Use Bronchoscopes, a line of five premium endoscopes for use in advanced diagnostic and therapeutic procedures. The introduction of the H-SteriScope portfolio has been a collaboration between Veran Medical Technologies, Inc., a wholly owned Olympus subsidiary, and Hunan Vathin Medical Instrument Co., Ltd.In April 2021, Ambu Inc. received Health Canada authorization for the aScope 4 Cysto, the company's unique flexible cystoscope platform for urology. Ambu’s aScope 4 Cysto is a cost-effective, high-quality flexible endoscope featuring excellent maneuverability and optics. Unlike traditional reusable endoscopes, single-use eliminates the significant capital, repair, and cleaning costs required to ensure a patient-ready instrument for every procedure. Each aScope 4 cystoscope is sterile from the package and ready when needed, enabling facilities to improve workflow efficiencies and reallocate staff from complex, time-consuming endoscope cleaning to more productive activities.
In December 2021, Medtronic Canada ULC, a subsidiary of Medtronic plc, received a Health Canada license for the Hugo robotic-assisted surgery (RAS) system for use in urologic and gynecologic laparoscopic surgical procedures, which make up about half of all robotic procedures performed in Canada. A modular, multi-quadrant platform indicated for urologic surgical procedures and gynecologic laparoscopic surgical procedures, the Hugo RAS system combines wristed instruments, 3D visualization, and a cloud-based surgical video capture option in Touch Surgery Enterprise with dedicated support teams specializing in robotics program optimization, service, and training.
In November 2022, PENTAX Medical launched the new Performance Endoscopic Ultrasound (EUS) system, a combination of the new ARIETTA 65 PX ultrasound scanner and their best-in-class J10 Series Ultrasound Gastroscopes in Canada. The ARIETTA 65 PX Performance ultrasound scanner is built for the endoscopic ultrasound practitioner focused on productivity. The system delivers brilliant imaging and value through its combination with the J10 Series Ultrasound Gastroscopes to efficiently manage high case volumes with ease.
On April 12, 2021, Cosmo Pharmaceuticals NV announced the FDA approval of the GI Genius intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy. The device is the first of its kind to obtain the FDA approval through the De Novo application. The device operates in real time to assist the endoscopist in the detection of lesions, is very simple to use and is compatible with all endoscopes. Cosmo is the sole manufacturer.On December 2019, Boston Scientific Corporation launched “EXALT Model D” a Single-Use Duodenoscope for endoscopic retrograde cholangiopancreatography procedures. This is the world’s first single-use duodenoscope. The third generation EXALT Model D Single-Use Duodenoscope has incorporated a number of design updates based on physician feedback that are intended to improve the overall user experience.
Thus, all these recent developments are expected to provide growth opportunities for the market over the forecast period.
Procedure-Based Insights
The endoscopy procedures market, by procedure, is endoscopic retrograde cholangiopancreatography (ERCP), endoscopic submucosal dissection (ESD), peroral endoscopic myotomy (POEM), endoscopic ultrasound (EUS), interventional pulmonology and laparoscopy, arthroscopy and bronchoscopy, colonoscopy and colposcopy, proctoscopy and thoracoscopy, and others. In 2022, the arthroscopy and bronchoscopy segment held the largest share of the market. However, the endoscopic retrograde cholangiopancreatography (ERCP) segment is expected to grow at the fastest rate during the forecasted years.Offering-Based Insights
The endoscopy procedures market, by offering, is segment into Endoscopes, ERCP Accessories, Visualization System, Head Positioner and Endotherapy Injection Needles, Sampling Device and Device Clip and Electrosurgical Knife, Endoscopic Ultrasound Guided Devices, Guidewire, Forceps, Snare, Irrigation/Insufflation Tubing Systems, Probes, Hemostats Clip, Polyps Traps, Single-use Valves, Trocar Sleeves and Tissue Scissors and Cutters, Retrieval Devices, and Others. In 2022, the endoscopes segment held the largest share of the market. The ERCP Accessories segment is expected to grow at the fastest rate during the forecasted period.Product Type-Based Insights
The endoscopy procedures market, by product type, is segment into disposable and reusable. The reusable segment held the largest share of the market in 2022 and disposable segment is expected to grow at the highest CAGR during the forecast period.End User-Based Insights
The endoscopy procedures market, by end user, is segment into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and others. In 2022, the hospitals and clinics segment held the largest share of the market. However, diagnostic laboratories are expected to grow fastest during the forecast period.A few of the major primary and secondary sources referred to while preparing the report on the endoscopy procedure market are the FDA (Food and Drug Administration), EUA (Emergency Use Authorization), EMA (European Medicines Agency), and EPA (Environmental Protection Agency)
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the endoscopy procedures market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global endoscopy procedures market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the endoscopy procedures market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction
2. Executive Summary
3. Research Methodology
4. Endoscopy Procedures Landscape
5. Endoscopy Procedures Market - Key Industry Dynamics
6. Endoscopy Procedures Market - Global Market Analysis
7. Global Endoscopy Procedures Market - Revenue and Forecast to 2030 - by Procedure
8. Global Endoscopy Procedures Market - Revenue and Forecast to 2030 - by Offering
9. Global Endoscopy Procedures Market - Revenue and Forecast to 2030 - by Product Type
10. Global Endoscopy Procedures Market - Revenue and Forecast to 2030 - by End User
11. Endoscopy Procedures Market - Revenue and Forecast to 2030 - Geographic Analysis
12. Endoscopic Procedures Market Industry Landscape
13. Company Profiles
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Stryker Corp
- Fujifilm Holdings Corp
- Merit Medical Systems Inc
- Smith & Nephew Plc
- Arthrex Inc
- Steris Plc
- Conmed Corp
- Olympus Corp
- Boston Scientific Corp
- Cook Medical Llc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 290 |
| Published | September 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 30.88 Billion |
| Forecasted Market Value ( USD | $ 53.2 Billion |
| Compound Annual Growth Rate | 7.0% |
| Regions Covered | Global |
